In this Q&A, Xie elaborates on the study's findings and explains why new diagnostic tools and treatment options for liver fibrosis are greatly needed. What is liver fibrosis and who is at risk?
An international study has identified two types of these so-called dysbioses in cystic fibrosis. They display ... Landmark Study Involving Babies in Ireland Supports Use of Cystic Fibrosis Drug in ...
Boehringer's phase 3 lung fibrosis trial hits primary endpoint, teeing up filings for Ofev successor
Boehringer Ingelheim has ended a decade of industrywide failures in idiopathic pulmonary fibrosis (IPF) by reporting a phase 3 win for a potentially first-in-class candidate and outlining plans to ...
The cystic fibrosis transmembrane conductance regulator (CFTR) is a complex protein that helps maintain fluid balance in several organs. Mutations in the CFTR protein can lead to symptoms of ...
Fibrosis is a leading cause of death and disability that occurs when normal healthy tissue is replaced with scar tissue. This harmful process can affect nearly all tissues and organ systems that ...
ATTO01310 targets IL31, while ATTO-002 hits both IL31 and IL13. The first clinical trial, of ATTO-002, is due to get underway next year. The financing was led by Goldman Sachs Alternatives ...
The UAB Gregory Fleming James Cystic Fibrosis Research Center is a university-wide interdisciplinary research center funded by the National Institutes of Health, the Cystic Fibrosis Foundation, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback